Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...
PanOptix delivers outstanding patient satisfaction and freedom from glasses; Vivity has a proven exceptionally low rate of visual disturbances2-8,**,Δ,§,^,‡ Alcon is committed to furthering innovation ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
FORT WORTH, October 5, 2026 - Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will highlight its innovation portfolio at the 2026 American Academy of ...
BENGALURU, India--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® Family of intraocular ...
Alcon (NYSE: ALC) today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in India. Utilizing Alcon’s most advanced IOL material in its 20+ years of IOL innovation, Clareon ...
CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent innovation launches, citing ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been implanted worldwide. 9,+ ...
TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...
Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...